However, because CXCL10 is secreted from monocytes/macrophages and CXCR3 is expressed in lymphocytes, the selective inhibition of a signal pathway of tumor cells in immunocompetent transgenic mice is difficult, especially when immune cells and tumor cells share a common signal pathway. The gene discussed is CXCL10; the disease is neoplasm.